Curaleaf Holdings, Inc. (CURA.TO)

CAD 1.31

(-2.24%)

Operating Expenses Summary of Curaleaf Holdings, Inc.

  • Curaleaf Holdings, Inc.'s latest annual operating expenses in 2023 was 442.75 Million USD , up 0.64% from previous year.
  • Curaleaf Holdings, Inc.'s latest quarterly operating expenses in 2024 Q2 was 152.91 Million USD , up 4.42% from previous quarter.
  • Curaleaf Holdings, Inc. reported a annual operating expenses of 583.09 Million USD in annual operating expenses 2022, up 9.15% from previous year.
  • Curaleaf Holdings, Inc. reported a annual operating expenses of 534.23 Million USD in annual operating expenses 2021, up 54.29% from previous year.
  • Curaleaf Holdings, Inc. reported a quarterly operating expenses of 150.9 Million USD for 2024 Q1, up 3.94% from previous quarter.
  • Curaleaf Holdings, Inc. reported a quarterly operating expenses of 138.6 Million USD for 2023 Q3, down -11.31% from previous quarter.

Annual Operating Expenses Chart of Curaleaf Holdings, Inc. (2023 - 2016)

Created with Highcharts 11.1.0YearsOperating Expenses201620172018201920202021202220230 CAD200000000 CAD400000000 CAD600000000 CAD

Historical Annual Operating Expenses of Curaleaf Holdings, Inc. (2023 - 2016)

Year Operating Expenses Operating Expenses Growth
2023 442.75 Million USD 0.64%
2022 583.09 Million USD 9.15%
2021 534.23 Million USD 54.29%
2020 346.26 Million USD 89.61%
2019 182.61 Million CAD 108.87%
2018 87.43 Million CAD 255.79%
2017 24.57 Million CAD 15370.09%
2016 158.84 Thousand CAD 0.0%

Peer Operating Expenses Comparison of Curaleaf Holdings, Inc.

Name Operating Expenses Operating Expenses Difference
Aurora Cannabis Inc. 158.53 Million CAD -179.273%
Avicanna Inc. 14.59 Million CAD -2934.303%
Avant Brands Inc. 5.65 Million CAD -7723.934%
Cardiol Therapeutics Inc. 29.53 Million CAD -1398.982%
Crescita Therapeutics Inc. 12.32 Million CAD -3493.802%
Knight Therapeutics Inc. 155.54 Million CAD -184.654%
MediPharm Labs Corp. 23.08 Million CAD -1818.106%
OrganiGram Holdings Inc. 277.81 Million CAD -59.373%
Canopy Growth Corporation 308.61 Million CAD -43.468%
Willow Biosciences Inc. 7.55 Million CAD -5761.218%
Auxly Cannabis Group Inc. 40.28 Million CAD -999.142%